Liposomes have been on the market as drug delivery systems for over 25 years. Their success comes from the ability to carry toxic drug molecules to the appropriate site of action through passive accumulation, thus reducing their severe side effects. However, the need for enhanced circulation time and site and time specific drug delivery, turned research focus on other systems, such as polymers. In this context, novel composites that combine the flexibility of polymeric nanosystems with the properties of liposomes gained a lot of interest. In the present work a mixed/chimeric liposomal system, composed of phospholipids and block copolymers, was developed and evaluated in regards with its feasibility as a drug delivery system. These innovativ...
The development of new polymer–liposome complexes (PLCs) as delivery systems is the key issue of thi...
The addition of polyethylene glycol (PEG) on the surface of liposomes increases their circulation ti...
In 1961, Bangham and his team invented liposomes, which are concentric bilayer vesicles. They are qu...
Liposomes have been on the market as drug delivery systems for over 25 years. Their success comes fr...
Thermosensitive liposomes are clinically-relevant nanocarriers which have been used to deliver chemo...
Chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) could be defined as mixed nanosystems due ...
The anticipated benefits of nano-formulations for drug delivery are well known: for nanomedicines to...
The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior o...
The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior o...
This research primarily focused on identifying the formulation parameters which control the efficacy...
The use of nano-sized synthetic polymers, comprised of therapeutic entities like drugs, genes or pep...
The anticipated benefits of nano-formulations for drug delivery are well known: for nanomedicines to...
Delivery of naked drugs in the body faces many challenges, such as poor solubility in blood and inte...
Liposomes can potentially serve as carrier systems for controlled delivery of drugs. The main goal o...
The investigation of colloidal properties of nanosystems represents a fundamental issue for the deve...
The development of new polymer–liposome complexes (PLCs) as delivery systems is the key issue of thi...
The addition of polyethylene glycol (PEG) on the surface of liposomes increases their circulation ti...
In 1961, Bangham and his team invented liposomes, which are concentric bilayer vesicles. They are qu...
Liposomes have been on the market as drug delivery systems for over 25 years. Their success comes fr...
Thermosensitive liposomes are clinically-relevant nanocarriers which have been used to deliver chemo...
Chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) could be defined as mixed nanosystems due ...
The anticipated benefits of nano-formulations for drug delivery are well known: for nanomedicines to...
The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior o...
The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior o...
This research primarily focused on identifying the formulation parameters which control the efficacy...
The use of nano-sized synthetic polymers, comprised of therapeutic entities like drugs, genes or pep...
The anticipated benefits of nano-formulations for drug delivery are well known: for nanomedicines to...
Delivery of naked drugs in the body faces many challenges, such as poor solubility in blood and inte...
Liposomes can potentially serve as carrier systems for controlled delivery of drugs. The main goal o...
The investigation of colloidal properties of nanosystems represents a fundamental issue for the deve...
The development of new polymer–liposome complexes (PLCs) as delivery systems is the key issue of thi...
The addition of polyethylene glycol (PEG) on the surface of liposomes increases their circulation ti...
In 1961, Bangham and his team invented liposomes, which are concentric bilayer vesicles. They are qu...